中國,北京——2025年9月4日——在伊斯蘭共和國巴基斯坦總理閣下的見證下,海杰亞醫(yī)療與巴基斯坦SHAHCO MEDICAL在第二屆中巴投資對接大會上簽署了戰(zhàn)略性諒解備忘錄(MoU)。
Beijing, China – September 4, 2025 – In a significant ceremony witnessed by His Excellency the Prime Minister of the Islamic Republic of Pakistan, Hygea Medical Technology Co., Ltd. of China and SHAHCO MEDICAL Pvt Ltd of Pakistan signed a strategic Memorandum of Understanding (MoU) today at the 2nd Pakistan-China B2B Investment Conference.
此次簽約儀式在巴基斯坦總理及多位高級部長的見證下舉行,標(biāo)志著中巴在醫(yī)療健康領(lǐng)域合作邁出重要一步。該諒解備忘錄致力于通過引入創(chuàng)新性的復(fù)合式冷熱消融(co-ablation)技術(shù),提升巴基斯坦癌癥治療水平。
The signing, which took place during the high-profile conference attended by the Pakistani Premier and senior ministers, marks a major step in strengthening Sino-Pakistani cooperation in the healthcare sector. The MoU is squarely focused on advancing cancer treatment capabilities in Pakistan through the introduction of innovative co-ablation technology.
巴基斯坦總理的出席與見證,凸顯了這一醫(yī)療項目所獲得的高層政治承諾,以及其與中巴經(jīng)貿(mào)和技術(shù)合作總體框架的契合。
The presence and witness of the Prime Minister of Pakistan underscore the high-level political commitment to this healthcare initiative and its alignment with the broader framework of Pakistan-China economic and technological collaboration.
該協(xié)議體現(xiàn)了海杰亞醫(yī)療與SHAHCO MEDICAL 公司的共同愿景,即通過創(chuàng)新、培訓(xùn)與合作,為減輕巴基斯坦的癌癥負擔(dān)作出重要貢獻。
This agreement reflects a shared vision between Hygea and SHAHCO to significantly contribute to reducing the cancer burden in Pakistan through innovation, training, and partnership.